Your browser doesn't support javascript.
loading
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
Charles-Schoeman, Christina; Buch, Maya H; Dougados, Maxime; Bhatt, Deepak L; Giles, Jon T; Ytterberg, Steven R; Koch, Gary G; Vranic, Ivana; Wu, Joseph; Wang, Cunshan; Kwok, Kenneth; Menon, Sujatha; Rivas, Jose L; Yndestad, Arne; Connell, Carol A; Szekanecz, Zoltan.
Afiliação
  • Charles-Schoeman C; Division of Rheumatology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA ccharles@mednet.ucla.edu.
  • Buch MH; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Dougados M; NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Bhatt DL; Université de Paris; Department of Rheumatology, Hôpital Cochin; Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Giles JT; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France.
  • Ytterberg SR; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Koch GG; Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Vranic I; Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Wu J; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Wang C; Pfizer Ltd, Tadworth, UK.
  • Kwok K; Pfizer Inc, Groton, Connecticut, USA.
  • Menon S; Pfizer Inc, Groton, Connecticut, USA.
  • Rivas JL; Pfizer Inc, New York, New York, USA.
  • Yndestad A; Pfizer Inc, Groton, Connecticut, USA.
  • Connell CA; Pfizer SLU, Madrid, Spain.
  • Szekanecz Z; Pfizer Inc, Oslo, Norway.
Ann Rheum Dis ; 82(1): 119-129, 2023 01.
Article em En | MEDLINE | ID: mdl-36137735
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Doenças Cardiovasculares / Antirreumáticos / Aterosclerose Tipo de estudo: Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Doenças Cardiovasculares / Antirreumáticos / Aterosclerose Tipo de estudo: Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article